The emergence of reproductive tourism

DUBLIN, December 13, 2021 / PRNewswire / – The report “Analysis of the Preimplantation Genetic Testing Market: Focus on Product, Application, Technology, End User, National Data 2021-2031” has been added to offer.

The global preimplantation genetic testing market was valued at $ 972.1 million in 2020 and should reach $ 2,725.7 million by 2031, registering a CAGR of 9.69% during the forecast period 2021-2031.

The growth is attributed to advanced maternal age around the world, increasing adoption of in vitro fertilization, heightened awareness of genetic testing, and increasing emphasis on predictive testing. In addition, the large and continued investments by biotechnology companies to improve genetic testing technology and to improve affordability have also promoted the importance of preimplantation genetic testing.

The exponential increase in the use of in vitro fertilization facilities as an option for healthy childbirth and the increasing affordability of genetic testing globally has created awareness as well as demand among consumers. which ultimately led companies to invest in the development of more such preimplantation genetic tests.

Companies such as Agilent Technologies, Inc. and Natera, Inc. have incorporated major strategies to strengthen their market presence through key developments. Other major market contributors include companies such as Thermo Fisher Scientific, PerkinElmer, Inc., Invitae Inc., and Igenomix.

Depending on the region, North America holds the largest share of the preimplantation genetic testing market due to a relaxed regulatory scenario and a large number of IVF facilities offering such PGT testing.

In addition, the substantial investments made by the biotech companies to improve the genetic testing facilities and advanced technologies as well as the increase in per capita income in the region is also fueling the growth of the respective market. Apart from that, the Asia Pacific The region is expected to grow at the fastest CAGR during the forecast period.

Market Report Coverage – Preimplantation Genetic Testing

Market segmentation

  • Product type – Reagents and consumables, kits and services
  • Application – Structural chromosome abnormalities, monogenic disorder and others
  • Technology – Polymerase chain reaction (PCR), next generation sequencing (NGS), in situ hybridization (ISH / FISH), microarray
  • End user – Diagnostic center, research center and others

Regional segmentation

  • North America – WE, Canada
  • EuropeFrance, Italy, UK, Spain, Netherlands, Russia, and Rest-of-Europe
  • Asia PacificChina, Japan, India, South Korea, Australia, and Rest-of-Asia Pacific (RoAPAC)
  • Rest of the world

Market growth drivers

  • Advancing maternal age around the world
  • An increase in adoption of in vitro fertilization
  • Increased awareness of genetic testing
  • Growing emphasis on predictive genetic testing for early detection

Market challenges

  • Ethical issues related to preimplantation genetic testing
  • High procedural cost associated with preimplantation genetic testing

Market opportunities

  • Lower cost of genomic sequencing
  • The emergence of reproductive tourism

Key questions addressed in this report:

  • What factors are driving the requirement for global preimplantation genetic testing on a global scale?
  • What are the different types of products available in the global preimplantation genetic testing market?
  • What are the main development strategies implemented by the main players to stand out in this global preimplantation genetic testing market?
  • What are the different technologies deployed in the global preimplantation genetic testing market?
  • How have strategic collaborations between major players spurred product development in the global preimplantation genetic testing market?
  • Who are the major companies dominating the global preimplantation genetic testing market?
  • Based on the type of application, which therapy in the global preimplantation genetic testing market is expected to experience massive increase in demand during the forecast period?
  • How is each segment of the global preimplantation genetic testing market expected to grow over the forecast period, and what revenue will be generated by each segment by the end of 2031?

Key companies profiled

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • BGI
  • Fulgent Genetics, Inc.
  • Igenomix
  • Illumina, Inc.
  • Invitae Corporation
  • Myriad Genetics, Inc.
  • MedGenome Labs Ltd.
  • Natera, Inc.
  • PerkinElmer, Inc.
  • Pac Genomics
  • Thermo Fisher Scientific Inc.

For more information on this report, visit

About is the world’s leading source for market research reports and international market data. We provide you with the latest data on international and regional markets, key industries, major companies, new products and the latest trends.

Media contact:

Research and markets
Laura Wood, senior
[email protected]

For EST office hours, call + 1-917-300-0470
For USA / CAN call toll free + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900

US Fax: 646-607-1904
Fax (outside the United States): + 353-1-481-1716

SOURCE Research and Markets

Related links

Comments are closed.